Cyclo Therapeutics Inc (CYTH)

[Lazarus]

The Q came out the other day and I actually missed it. I read the 8k that states:

On November 9, 2018, CTD Holdings, Inc. announced that it had retained Torreya Capital, LLC, as its strategic advisor to support business development.

Then I looked at the Q and that explains it all:

The are down to $216k in shareholder equity (which by my math is around .002 per share book value)

Year over year sales for the 9 mos is down significantly - over 20%

Loss of $2,889,474 for the 9 mos (~$963k per quarter on average)

Bills are stacking up - current assets at 1,710,902 against current liabilities of 1,654,922

Bottom line is the company needs more money and they need outside help to "support business developement". They either need to find investors to put up more millions or a buyout.

Either way -- its looking quite tenuous to me so I'll stay on the sidelines.

As I see it the risk reward possibilities are:

They get funding -- stock price may or may not hold depending on the terms of the deal.

They get a buyout at around $2.00 per share like VTESSE managed (best case scenario).

Neither of the above (worst case scenario) and stock price follows.
________________

LINK TO Q